News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media
AI may predict spread of lung cancer to brain
Method may inform personalized cancer treatments Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen the risk of it spreading to the brain, or waiting to see if lung surgery alone proves sufficient. When up […]
In the Media
Medicare approves genetic test for solid tumors
Test can quickly identify treatable cancer mutations, guide precision therapy A genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis has been approved for reimbursement by the Centers for Medicare & Medicaid Services (CMS). The test, known as GatewaySeq, identifies […]
In the Media, Research
Device for noninvasive brain biopsies via blood draw moves closer to market approval
A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) “Breakthrough Device” designation. The device includes technology from Washington University in St. Louis and developed by Cordance Medical Inc., a medical device company in Mountain View, Calif. The designation […]
In the Media
Comprehensive Head & Neck Tumor Center established at Siteman Cancer Center
Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital, a member of BJC HealthCare, have established a comprehensive Head & Neck Tumor Center, a collaborative, multispecialty practice of Washington University physicians and researchers whose mission is to provide cutting-edge care for patients with head and neck cancers as well as benign tumors and […]
In the Media, Research
Study reveals how treatment-resistant prostate cancer provides its own hormonal fuel
A new study in mice, led by researchers at Washington University School of Medicine in St. Louis, explains how prostate cancer senses a drop in testosterone levels due to common anti-hormone therapy and then begins making cholesterol — a necessary precursor to testosterone — to generate its own testosterone to fuel tumor growth. The study […]
In the Media
Siteman Cancer Center ranked No. 10 among U.S. cancer centers
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has been named No. 10 among cancer centers nationally by U.S. News & World Report. The recognition is part of the overall ranking of Barnes-Jewish and Washington University, which are No. 11 on the news magazine’s 2022-23 “Best Hospitals” list, released today. Siteman […]
In the Media
Promising role for whole genome sequencing in guiding blood cancer treatment
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the […]
Clinical, In the Media
Siteman Cancer Center named among top U.S. cancer centers
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has been named among the top cancer centers nationally by U.S. News & World Report. The recognition is part of the overall ranking of Barnes-Jewish and Washington University, which are No. 18 on the news magazine’s 2020-21 “Best Hospitals” list, released today. Siteman […]
In the Media
Siteman Cancer Center director, benefactor named 2019 citizens of the year
Two people who shared the vision to build what is now Siteman Cancer Center have been recognized as citizens of the year. Timothy J. Eberlein, MD, Siteman’s director, and Alvin J. Siteman, the benefactor for whom the center is named, were recognized by the St. Louis Post-Dispatch after being selected by a committee of past recipients. The honor, typically given […]
In the Media